User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Mutagenic activation of benzo[a]pyrene by human red blood cells.

Primary tabs

Lo Jacono, F. [UCL] Stecca, C. [UCL] Duverger, M. [UCL]

The induction of sister-chromatid exchanges (SCEs) and micronuclei (MN) was used as an endpoint to evaluate the cytogenetic effects of benzo[a]pyrene (B(a)P) activated by human red blood cells and S9 mix. Human erythrocytes can metabolically activate B(a)P. It was shown that both human erythrocytes and S9 mix activate B(a)P and that the resulting excess SCE and MN depend in a linear manner on the B(a)P dose. HPLC analysis suggested that quinone derivatives formed by the red blood cells are responsible for the cytogenetic abnormalities observed.

Document type Article de périodique (Journal article) – Journal Article, Research Support, Non-U.S. Gov't
Publication date 1992
Journal information "Mutation research" - Vol. 268, no. 1, p. 21-6 (1992)
issn 0027-5107
Publication status Publié
Affiliation UCL - MD/MIGE - Département de microbiologie, d'immunologie et de génétique
MESH Subject Benzo(a)pyrene - metabolism - toxicity ; Biotransformation ; Cells, Cultured ; Chromatography, High Pressure Liquid ; Dose-Response Relationship, Drug ; Erythrocytes - metabolism ; Humans ; Liver - metabolism ; Liver Extracts - metabolism ; Lymphocytes - drug effects ; Micronuclei, Chromosome-Defective - drug effects ; Mutagenicity Tests ; Sister Chromatid Exchange - drug effects
Links
Bibliographic reference Lo Jacono, F. ; Stecca, C. ; Duverger, M.. Mutagenic activation of benzo[a]pyrene by human red blood cells.. In: Mutation research, Vol. 268, no. 1, p. 21-6 (1992)
Permanent URL http://hdl.handle.net/2078.1/24663